GoldBamboo.com - Knowledge is strong medicine
  

Indicated Prevention with At-Risk Gamblers - Article


  Not Signed In - Sign In / Register






Youth Risk Behavior Surveillance System

YRBSS


Clinical Trial: Indicated Prevention with At-Risk Gamblers

This study is currently recruiting patients.

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)

Purpose

The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.

Condition Treatment or Intervention Phase
Gambling
 Behavior: Brief Personal Feedback Intervention
 Behavior: Cognitive Behavioral Therapy
Phase II

MedlinePlus related topics:  Mental Health

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Further Study Details: 

Expected Total Enrollment:  225

Study start: July 2003;  Expected completion: June 2006

Participants in this study will be randomly assigned to a personal feedback intervention (PFI), cognitive behavioral therapy (CBT), or assessment only for 3 years. The PFI intervention will be delivered in a single session; CBT will be delivered in six weekly sessions. Measures will include the NORC DSM Screen for Problem Gambling (NODS), the South Oaks Gambling Screen (SOGS), Gambling Quantity and Perceived Norms, Perceived Injunctive Gambling Norms, Gambling Problems Index, gambling frequency, attitudes and beliefs about gambling and self-control, readiness to change, gambling expectancies, gambling motives, gambling risk perception, psychiatric symptoms, assertiveness, coping skills, substance use, alcohol-related problems, self-determination, and social desirability.

Eligibility

Ages Eligible for Study:  17 Years   -   24 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • College student
  • South Oaks Gambling Screen (SOGS) score between 3 and 4 or SOGS score of 5

Location and Contact Information


Washington
      University of Washington; Department of Psychiatry and Behavioral Sciences, Seattle,  Washington,  98195,  United States; Recruiting
Ty W. Lostutter, BS  206-543-0473    tylost@u.washington.edu 
Mary E. Larimer, PhD,  Principal Investigator
Clayton Neighbors, PhD,  Sub-Investigator

More Information

Study ID Numbers:  MH67026-01A1
Record last reviewed:  August 2004
Last Updated:  October 13, 2004
Record first received:  February 20, 2004
ClinicalTrials.gov Identifier:  NCT00078273
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Youth Risk Behavior Surveillance System.

October 11, 2008



Page Updated: November 22, 2004
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.